11.11.2013 NEXUS AG  DE0005220909

DGAP-Adhoc: NEXUS AG: Substantial sales and profit increases in Q3 2013


 
NEXUS AG / Key word(s): Quarter Results 11.11.2013 08:52 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Villingen-Schwenningen, 11 November 2013: NEXUS AG, Villingen Schwenningen, listed in Prime Standard, had sales from KEUR 52,237 (+19.2%) in the first nine months 2013 following KEUR 43,813 in the previous year and achieved an improved result before taxes and interest (EBIT) of KEUR 4,754 compared to KEUR 3,985 (+19.3%) in the previous year. The result before taxes amounted to KEUR 5,112 following KEUR 4,351 (+17.5%) in the previous year. The EBITDA increased to KEUR 9,945 (+16.3%) in the fi rst nine months following KEUR 8,552 (Q3-2012), and the result after taxes reached KEUR 4,873 following KEUR 4,299 (+13.4%) in the previous year. Sales in the core business, Healthcare Software, increased by 12.2% to KEUR 45,998 (previous year: KEUR 40,499) in the first nine months. The Healthcare Service Division closed considerably above previous year's level with sales of KEUR 6,239 following KEUR 2,814. In the third quarter, the NEXUS Group had sales of KEUR 17,752 following KEUR 15,041 in the previous year (+18.0%). The result before taxes in the third quarter amounted to KEUR 1,575 and consequently was approx. 20% higher than the value of the previous year (Q3 2012: KEUR 1.321). The operative cash flow is lower than the previous year's level at KEUR 7,189(previous year: KEUR 7,663). The foreign share of Group sales was 42.8% in the first nine months compared to 45.1% in the same period of the previous year. NEXUS AG had equity capital of approx. EUR 71.5 million and cash reserves and securities in the amount approx. EUR 24.0 million on 30 September 2013. There are no essential bank liabilities. The equity capital rate was 69.8%. --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: NEXUS - the eHealth specialist - develops and sells modular software solutions internationally for healthcare systems in the areas of 'Clinical Information Systems' (CIS), 'Diagnostic Information Systems' (DIS) and 'IT Services'. Comprehensive solutions for hospitals and psychiatric institutions are designed and supported within NEXUS / CIS. The solutions of NEXUS / DIS cover special ward and specialist areas for radiology, pathology as well as for gynecology / obstetrics and intensive care medicine. NEXUS bets on modern, modular software architecture in all product areas, which enables flexible and step-by-step introduction of NEXUS systems. More than 600 staff members in the NEXUS Group develop software solutions for the healthcare sector, with which approximately 158,600 users in 23 countries work. 11.11.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: NEXUS AG Auf der Steig 6 78052 Villingen-Schwenningen Germany Phone: +49 (0)7721 8482-0 Fax: +49 (0)7721 8482-311 E-mail: [email protected] Internet: www.nexus-ag.de ISIN: DE0005220909 WKN: 522090 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------


Die wichtigsten Finanzdaten auf einen Blick
  2015 2016 2017 2018 2019 2020 2021e
Umsatzerlöse1 97,27 107,05 119,08 136,47 147,65 162,94 169,00
EBITDA1,2 18,88 21,02 23,72 26,71 33,95 36,64 39,50
EBITDA-Marge3 19,41 19,64 19,92 19,57 22,99 22,49 23,37
EBIT1,4 9,64 10,93 13,32 15,18 17,44 19,92 22,90
EBIT-Marge5 9,91 10,21 11,19 11,12 11,81 12,23 13,55
Jahresüberschuss1 9,64 8,61 10,16 11,00 12,12 15,09 18,10
Netto-Marge6 9,91 8,04 8,53 8,06 8,21 9,26 10,71
Cashflow1,7 18,15 16,54 21,68 20,24 24,62 30,95 29,50
Ergebnis je Aktie8 0,48 0,52 0,62 0,69 0,69 0,96 1,23
Dividende8 0,14 0,15 0,16 0,17 0,18 0,19 0,21
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Ebner Stolz

INVESTOR-INFORMATIONEN
©boersengefluester.de
Nexus
WKN Kurs in € Einschätzung Börsenwert in Mio. €
522090 72,900 Kaufen 1.148,34
KGV 2022e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
54,40 31,33 1,74 111,13
KBV KCV KUV EV/EBITDA
9,38 37,11 7,05 31,79
Dividende '19 in € Dividende '20e in € Div.-Rendite '20e
in %
Hauptversammlung
0,18 0,19 0,26 27.04.2021
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
11.05.2021 10.08.2021 09.11.2021 09.03.2021
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
4,52% 17,88% 42,94% 62,00%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu NEXUS AG  ISIN: DE0005220909 können Sie bei DGAP abrufen

Software , 522090 , NXU , XETR:NXU